Christopher M. Jewell, Chief Scientific Officer: Cartesian Therapeutics RNAC Planned sale · Filed 01/13

Trade details

Type: Planned sale notice
Stock: Cartesian Therapeutics RNAC
Person: Christopher M. JewellChief Scientific Officer
Planned sale date: 26/01/13
Filed: 26/01/13

More to sell after $213.8K in 3 months

Cartesian Therapeutics trades, last 26 weeks

What else happened in Cartesian Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/14~02/12

Christopher M. Jewell's recent trades

Christopher M. JewellChief Scientific Officer
Planned saleCartesian Therapeutics
Planned sale
Cartesian Therapeutics
RNAC
$12.1K
1,510 sh
$12.1K
Filed 01/09
Traded 01/09
Christopher M. JewellChief Scientific Officer
Planned saleCartesian Therapeutics
Planned sale
Cartesian Therapeutics
RNAC
$192.6K
26,935 sh
$192.6K
Filed 25/11/19
Traded 25/11/19
Christopher M. JewellChief Scientific Officer
SellCartesian Therapeutics
Sell
Cartesian Therapeutics
RNAC
$21.6K
1,286 sh
$21.6K
Filed 25/01/07
Traded 25/01/06
Christopher M. JewellChief Scientific Officer
SellCartesian Therapeutics
Sell
Cartesian Therapeutics
RNAC
$21.1K
1,264 sh
$21.1K
Filed 25/01/07
Traded 25/01/03
Christopher M. JewellChief Scientific Officer
SellCartesian Therapeutics
Sell
Cartesian Therapeutics
RNAC
$303.1K
18,550 sh
$303.1K
Filed 24/11/18
Traded 24/11/14

Christopher M. Jewell, Chief Officer — plans to sell 9,000 sh of Cartesian Therapeutics RNAC · $68.9K · around 01/13 | Whalegun